Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2022-36277
Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
SQL injection vulnerability in TCMAN GIM
Source: NVD (National Vulnerability Database)
Vulnerability Description
The 'sReferencia', 'sDescripcion', 'txtCodigo' and 'txtDescripcion' parameters, in the frmGestionStock.aspx and frmEditServicio.aspx files in TCMAN GIM v8.0.1, could allow an attacker to perform persistent XSS attacks.
Source: NVD (National Vulnerability Database)
CVSS Information
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:L
Source: NVD (National Vulnerability Database)
Vulnerability Type
在Web页面生成时对输入的转义处理不恰当(跨站脚本)
Source: NVD (National Vulnerability Database)
Vulnerability Title
TCMAN GIM 跨站脚本漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
TCMAN GIM是TCMAN公司的一款 CMMS。可用于各个领域:工业、设施、医疗保健、车队和维护服务。 TCMAN GIM v8.0.1版本存在跨站脚本漏洞,该漏洞源于frmGestionStock.aspx 和 frmEditServicio.aspx 文件中的sReferencia、sDescription、txtCodigo和txtDeripcion参数允许攻击者执行XSS 攻击。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
TCMANGIM v8.0.1 -
II. Public POCs for CVE-2022-36277
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2022-36277
Please Login to view more intelligence information
IV. Related Vulnerabilities
V. Comments for CVE-2022-36277

No comments yet


Leave a comment